Vertex Pharmaceuticals VRTX reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Vertex Pharmaceuticals beat estimated earnings by 2.27%, reporting an EPS of $3.6 versus an estimate of $3.52.
Revenue was up $403.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 4.67% drop in the share price the next day.
Here's a look at Vertex Pharmaceuticals's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | 3.49 | 3.29 | 3.08 | 2.28 |
EPS Actual | 3.52 | 3.37 | 3.56 | 3.11 |
Revenue Estimate | 2.08B | 2.00B | 1.86B | 1.72B |
Revenue Actual | 2.10B | 2.07B | 1.98B | 1.79B |
To track all earnings releases for Vertex Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.